Crossmark

Grade group 2 (10% ≥ GP4) patients have very similar malignant potential with grade group 1 patients, given the risk of intraductal carcinoma of the prostate

Crossref DOI link: https://doi.org/10.1007/s10147-020-01841-4

Published Online: 2021-01-01

Published Print: 2021-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kato, Masashi https://orcid.org/0000-0002-3454-3658
Hirakawa, Akihiro

Sato, Hiroyuki

Hanazawa, Ryoichi

Naito, Yushi

Tochigi, Kosuke

Sano, Tomoyasu

Ishida, Shohei

Funahashi, Yasuhito

Fujita, Takashi

Matsukawa, Yoshihisa

Hattori, Ryohei

Tsuzuki, Toyonori
License Information

Text and Data Mining valid from 2021-01-01

Version of Record valid from 2021-01-01
More Information

Article History

Received: 11 August 2020

Accepted: 16 November 2020

First Online: 1 January 2021

Compliance with ethical standards

:

: The authors declare no conflict of interest and no fund.

Document is current

Any future updates will be listed below